on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights is committed to eliminating Antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
The meeting is focussed on the challenges of developing new agents for AMR that stretches from medicinal chemistry right through to the collective efforts of the international community to produce new antibiotics.
01/09/2020 - 04/09/2020 | Dublin (Ireland)
Workshop Antimicrobial Resistance on Biomaterials
Brings together leaders in science, medicine and industry to discuss how antimicrobial surfaces can be used rationally to reduce the risk of antimicrobial resistance evolution and spread on medical implants.
02/09/2020 - 02/09/2020 | Thesinge (NL)
Latest news on AMR
WASH Community Programmes Key to Overcome Antimicrobial Resistance in Low and Middle-Income Countries
A 2019 meeting of international experts on behalf of the Global Hygiene Council, and resulting position paper recently published in the American Journal of Infection Control, further validates the crucial position of hygiene in combatting AMR, demonstrating how an improvement in hygienic practices in the community and home settings, can result in a mirrored reduction in antibiotic prescribing and an associated reduction in selection pressure for the development of resistance.
The Need to Address AMR Burden During COVID-19 Times
As per the WHO, only a small proportion of COVID-19 patients need antibiotics to treat subsequent bacterial infections and has issued guidance not to provide antibiotic treatment to patients with mild COVID-19 illness. However, people are consuming high doses of antibiotics as a precautionary measure.